Pattern lists this material for controlled laboratory research
Proteins such as Cr FAP65AH1, Cr FAP65AH2, Cr FAP65AH1V12P, Cr FAP65AH2V12P and GST were affinity purified and individually overlaid on the blots at a concentration of 5 g/ml in TBST containing 1% BSA), overnight (16 h at 4 C)
Testicular toxicity: evaluation during drug development
In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
En humanos los usuarios reportan cambios entre 2 y 6 semanas, aunque la evidencia clnica directa en personas es an limitada
We loaded the MIMIC-IV dataset in the original CSV file format into DuckDB v1.3.2